We're Hopeful That Nuvalent (NASDAQ:NUVL) Will Use Its Cash Wisely - simplywall.st
Yesterday • Google News
Nuvalent Inc (NUVL)
US$ 71.642.39%
Price Chart
Key Statistics
Market Cap
$ 5.62B
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
667.4K
52W High
$ 113.51
52W Low
$ 55.53
Dividend Yield
0.00%
Beta
1.34
Technicals
50-Day MA
72.5632
200-Day MA
83.4112
52 Week High
113.51
52 Week Low
55.535
About NUVL
Nuvalent, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.
Employees
162
Headquarters
Cambridge, MA
CEO
Dr. James R. Porter Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg